- Researchersidentified novel HIV-1 capsid inhibitors (CAIs) with uniquely potent antiviral activity and a favorable resistance profile orthogonal to existing antiretrovirals (ARVs).
Why this matters
- While HIV capsid (CA) plays an essential role in multiple stages of the vi...
You’ve reached the visitor articles limit
reserved for healthcare professionals
Register to read more
Already have an account? Login now